Lost years of life due to the mortality from diseases of the urinary system in the industrial region of Kazakhstan with air pollution

封面

如何引用文章

全文:

详细

Introduction. The relevance of the epidemiological problems of loss of years due to diseases of the kidney and urinary tract is due to the progressive gain in the number of patients in many regions and countries of the World.

Purpose. Estimation of years of life lost due to the mortality from diseases of the urinary system (DUS) in the Pavlodar region, which is one of the industrial regions of Kazakhstan.

Materials and methods. Medical-demographic (mortality rates) and medical-statistical (primary morbidity rates) data was obtained from the Department of Statistics of the Republican Center for Electronic Health Care of the Republic of Kazakhstan (RCEHC RK). The study period was eight years (from 2015 to 2022). The Years of Life Lost (YLL) indicator was calculated according to methodological recommendations. An assessment of the relationships between population health indicators for pathologies of the urinary system (US) with social factors (gross domestic product per capita — GDP), and environmental indicators (ecological and meteorological) as possible causes of adverse events in human health was carried out using correlation and time series analysis.

Results. In the structure of years of life lost due to the mortality from US organs, chronic renal failure (CRF, 55.96–65.85%) led. In the regional center of Pavlodar, there was a peak in years lost in mortality from DUS over 2021 (3.3‰ YLLs), during the COVID-19 pandemic. According to the average annual losses by age groups, in the Pavlodar region, the maximum losses were detected in the elderly (10.5‰ YLLs) and senile (15.8‰ YLLs) age. An excess of the maximum one-time concentrations of pollutants in the atmospheric air above the MPC level with the highest pollution level in 2018 was registered. Correlation analysis showed a high level of correlation between the loss of years of life because of the mortality due to US diseases with atmospheric air pollution in Ekibastuz (r  = 0.80), weak — in Pavlodar region (r  = 0.28) and low — in Pavlodar (r = 0.13).

Limitations. Of the environmental pollution factors, only atmospheric air pollution factors were studied, which does not reflect all the possible effects of environmental pollution on population health. In the group of reasons with code R, the conclusion “old age” prevailed, which may have led to an inaccurate analysis of the causes of death.

Conclusion. Regional connections between the loss of years of life due to mortality due to US diseases with atmospheric air pollution and temperature in the winter season, as well as newly identified morbidity with atmospheric air pollution, have been identified.

Contribution:
Bibitova Sh.S., Galiakparova Zh.Zh., Zhaksylyk M.A., Dyagilev M.A., Kosach V.S. — collection and processing of material;
Lopuha I.V., Oralova R.N., Sandybayeva A.K., Khashimov Zh.U. — text writing;
Dyussembaeva N.K. — concept and design of the study, approval of the final version of the article;
Rybalkina D.Kh. — editing, responsibility for the integrity of all parts of the article;
Drobchenko Ye.A. — statistical data processing.

Conflict of interest. The authors declare no conflict of interest.

Acknowledgment: the work was carried out within the framework of the project “Setting Target Indicators of Environmental Quality for the Pavlodar Region”.

Received: November 8, 2023 / Revised: Nnovember 20, 2023 / Accepted: January 28, 2024 / Published: March 15, 2024

作者简介

Shynar Bibitova

Medical University of Karaganda

编辑信件的主要联系方式.
Email: Bibitova@qmu.kz

Resident at the «Nephrology, adult, pediatric», NJSC «Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: Bibitova@qmu.kz

哈萨克斯坦

Zhuldyz Galiakparova

Medical University of Karaganda

Email: Galiakparova@qmu.kz

Resident at the «Nephrology, adult, pediatrics», Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: Galiakparova@qmu.kz

哈萨克斯坦

Mukhit Zhaksylyk

Medical University of Karaganda

Email: ZhaksylykM@qmu.kz

Resident at the «Nephrology, adult, pediatrics», Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: ZhaksylykM@qmu.kz

哈萨克斯坦

Irina Lopuha

Medical University of Karaganda

Email: Lopuha@qmu.kz

Resident at the Adult and Pediatric Nephrology, Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: Lopuha@qmu.kz

哈萨克斯坦

Roza Oralova

Medical University of Karaganda

Email: OralovaR@qmu.kz

Resident at the «Adult and Pediatric Nephrology», Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: OralovaR@qmu.kz

哈萨克斯坦

Ainura Sandybayeva

Medical University of Karaganda

Email: Sandybaeva_A@qmu.kz

Resident at the «Nephrology, adult, pediatrics», Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: Sandybaeva_A@qmu.kz

哈萨克斯坦

Zhakhongir Khashimov

Medical University of Karaganda

Email: HashimovZ@qmu.kz

Resident at the «Nephrology, adult, pediatrics», Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: HashimovZ@qmu.kz

哈萨克斯坦

Nailya Dyussembaeva

Medical University of Karaganda; Institute of Public Health and Occupational Health

Email: N.Dyusembaeva@qmu.kz
ORCID iD: 0000-0002-0555-1333

MD, PhD, DSci., professor of the Department of Clinical Pharmacology and Evidence-based Medicine; NJSC «Medical University of Karaganda», Karaganda, 100008, Kazakhstan; Institute of Public Health and Occupational Health, 100012, Karaganda, Kazakhstan

e-mail: N.Dyusembaeva@qmu.kz

哈萨克斯坦

Dina Rybalkina

Medical University of Karaganda; Institute of Public Health and Occupational Health

Email: ystas666@list.ru
ORCID iD: 0000-0002-2041-1259

MD, PhD, Associate Professor, Dept. Internal Medicine; NJSC «Medical University of Karaganda», Karaganda, 100008, Kazakhstan; Institute of Public Health and Occupational Health, Karaganda, 100012, Kazakhstan

e-mail: ystas666@list.ru

哈萨克斯坦

Yelena Drobchenko

Medical University of Karaganda

Email: lena_drobchenko@mail.ru
ORCID iD: 0000-0001-9291-7585

MD, teacher of the Department of Informatics and Biostatistics; Medical University of Karaganda, Karaganda, 100008, Kazakhstan

e-mail: lena_drobchenko@mail.ru

哈萨克斯坦

Maxim Dyagilev

«EKOEXPERT» LLP

Email: info@ecoexpert.kz

Environmental engineer, «EKOEXPERT» LLP, Karaganda, 100008, Kazakhstan

e-mail: info@ecoexpert.kz

哈萨克斯坦

Valeria Kosach

«EKOEXPERT» LLP

Email: kosach@ecoexpert.kz

Director design sector, «EKOEXPERT» LLP, Karaganda, 100008, Kazakhstan

e-mail: kosach@ecoexpert.kz

哈萨克斯坦

参考

  1. Smirnov A.V., Dobronravov V.A., Kayukov I.G., Bodur-Oorzhak A.O., Esayan A., Kucher A. Epidemiology and socio-economic aspects of chronic kidney disease. Nefrologiya. 2006; 10(1): 7–13. https://elibrary.ru/jueprj (in Russian)
  2. Institute for Health Metrics and Evaluation. GBD Compare. Available at: https://vizhub.healthdata.org/gbd-compare/#
  3. Coresh J., Astor B.C., Greene T., Eknoyan G., Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003; 41(1): 1–12. https://doi.org/10.1053/ajkd.2003.50007
  4. Smirnov A.V., Shilov E.M., Dobronravov V.A., Kayukov I.G., Bobkova I.N., Shvetsov M.Yu., et al. National recommendations for chronic kidney disease: basic principles of screening, diagnosis, prevention and approaches to treatment. Nefrologiya. 2012; 16(1): 89–115. https://elibrary.ru/njwage (in Russian)
  5. Kul’chenko N.G. Epidemiology of kidney disease in patients with COVID-19. Issledovaniya i praktika v meditsine. 2020; 7(3): 74–82. https://doi.org/10.17709/2409-2231-2020-7-3-7 https://elibrary.ru/ywialj (in Russian)
  6. Campi R., Rebez G., Klatte T. et al. Effect of smoking, hypertension and lifestyle factors on kidney cancer – perspectives for prevention and screening programmes. Nat Rev Urol. 2023; 20(11): 669-681. https://doi.org/10.1038/s41585-023-00781-8
  7. Umurzakov Kh.T., Kaydarova D.R., Apsalikov B.A., Shalgumbaeva G.M., Ibraev A., Sagidullin S.O. Kidney cancer epidemiology in Kazakhstan, 2010–2019. Onkologiya i radiologiya Kazakhstana. 2020; (4): 12–7. https://elibrary.ru/tecbrh
  8. D’yakov S.S., Tel’manova Zh.B., Bilyalova Z.A., Azhetova Zh.R., Igisinova G.S., Orozbaev S.T., et al. Assessment of changes in indicators of oncological care for kidney cancer in Kazakhstan. Onkologiya i radiologiya Kazakhstana. 2022; (4): 4–9. https://doi.org/10.52532/2521-6414-2022-4-66-4-9 (in Russian)
  9. Bevzenko T.B. Chronic kidney disease and ecology. Pochki. 2013; (2): 17–22. https://elibrary.ru/qywrir (in Russian)
  10. Berkinbaev S.F., Tundybaeva M.K., Dzhunusbekova G.A., Musagalieva A.T., Dan’yarova L.B., Leonovich T.N., et al. Assessment of the prevalence of renal dysfunction among residents of Almaty and the Almaty region. Medicine (Almaty). 2016; (9): 22–9. (in Russian)
  11. Rumyantseva E.I. Chronic kidney disease as a global public health problem: trends in morbidity and mortality. Problemy standartizatsii v zdravookhranenii. 2021; (1–2): 41–9. https://doi.org/10.26347/1607-2502202101-02041-049 https://elibrary.ru/tfhkjb (in Russian)
  12. Nursultanova L.N. Prevalence of chronic kidney disease in Kazakhstan (literature review). Vestnik Kazakhskogo natsional’nogo meditsinskogo universiteta. 2020; (4): 291–4. https://elibrary.ru/sypxrq (in Russian)
  13. Kanatbaeva A.B., Kabulbaev K.A., Naushabaeva A.E., Nurbekova A.A. Results of the screening for chronic kidney disease in population of Almaty-city. Nefrologiya i dializ. 2012; 14(2): 109–13. https://elibrary.ru/pcfxvx (in Russian)
  14. Medinform. The main indicators of public health and the activities of healthcare organizations of the Republic of Kazakhstan from 2000 to the present. Available at: http://medinfo.kz/meddps3.jsp (in Russian)
  15. IEC Kazexpo. The industry of the Pavlodar region. Available at: https://kazexpo.kz/region-pav/promyshlennost-pavlodarskogo-regiona (in Russian)
  16. El.kz. Iskakova A. Pavlodar region is subject to high anthropogenic pollution; 2023. Available at: https://el.kz/ru/pavlodarskaya-oblast-podverzhena-vysokomu-tehnogennomu-zagryazneniyu_68089/ (in Russian)
  17. Rostovtsev V.N., Lomat’ L.N., Ryabkova O.I., Marchenkova I.B., Kuzmenko V.E. Methodology for a Comprehensive Assessment of Health Losses as a Result of Morbidity and Mortality [Metodika kompleksnoy otsenki poter’ zdorov’ya v rezul’tate zabolevaemosti i smertnosti]. Minsk; 2008. (in Russian)
  18. Environmental Protection in the Republic of Kazakhstan 2018–2022: Statistical Collection [Okhrana okruzhayushchey sredy v Respublike Kazakhstana 2018–2022: Statisticheskiy sbornik]. Astana; 2023. (in Russian)
  19. Chen Y., Cao F., Xiao J.P., Fang X.Y., Wang X.R., Ding L.H., et al. Emerging role of air pollution in chronic kidney disease. Environ. Sci. Pollut. Res. Int. 2021; 28(38): 52610–24. https://doi.org/10.1007/s11356-021-16031-6
  20. McClellan A.C., Plantinga L., McClellan W.M. Epidemiology, geography and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2012; 21(3): 323–8. https://doi.org/10.1097/mnh.0b013e3283521dae
  21. Ministry of Ecology, Geology and Natural Resources of the Republic of Kazakhstan. Information bulletin on the state of the environment in the Pavlodar region. Pavlodar; 2022. (in Russian)
  22. Mogilyuk S.V., Poukh M.M. Ecology of Pavlodar Region [Ekologiya Pavlodarskoy oblasti]. Pavlodar: EKO; 2019. (in Russian)
  23. Pandey A.R., Poudyal A., Adhikari B., Shrestha N. Burden of chronic kidney disease in Nepal: An analysis of the burden of disease from 1990 to 2019. PLOS Glob. Public Health. 2023; 3(7): e0001727. https://doi.org/10.1371/journal.pgph.0001727.
  24. Laucyte-Cibulskiene A., Ward L.J., Ebert T., Tosti G., Tucci C., Hernandez L., et al. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality. Biol. Sex Differ. 2021; 12(1): 50. https://doi.org/10.1186/s13293-021-00393-0
  25. Minutolo R., Gabbai F.B., Chiodini P., Provenzano M., Borrelli S., Garofalo C., et al. Sex Differences in the progression of CKD among older patients: pooled analysis of 4 cohort studies. Am. J. Kidney Dis. 2020;75(1): 30–8. https://doi.org/10.1053/j.ajkd.2019.05.019
  26. Carriazo S., Aparicio-Madre M.I., Tornero-Molina F., Fernández-Lucas M., Paraiso-Cuevas V., González-Parra E., et al. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020. Nephrol. Dial. Transplant. 2022; 37(11): 2253–63. https://doi.org/10.1093/ndt/gfac234
  27. Swartling O., Rydell H., Stendahl M., Segelmark M., Trolle Lagerros Y., Evans M. CKD progression and mortality among men and women: a nationwide study in Sweden. Am. J. Kidney Dis. 2021; 78(2): 190–9.e1. https://doi.org/10.1053/j.ajkd.2020.11.026
  28. Wyld M.L., De La Mata N.L., Hedley J., Kim S., Kelly P.J., Webster A.C. Life years lost in children with kidney failure: a binational cohort study with multistate probabilities of death and life expectancy. J. Am. Soc. Nephrol. 2023; 34(6): 1057–68. https://doi.org/10.1681/ASN.0000000000000118
  29. Kula A.J., Prince D.K., Katz R., Bansal N. Mortality burden and life-years lost across the age spectrum for adults living with CKD. Kidney360. 2023; 4(5): 615–21. https://doi.org/10.34067/KID.0000000000000097
  30. Chan T.C., Chuang Y.H., Hu T.H., Lin Y.H., Hwang J.S. Mortality risk and years of life lost for people with reduced renal function detected from regular health checkup: A matched cohort study. Prev. Med. Rep. 2023; 31: 102107. https://doi.org/10.1016/j.pmedr.2022.102107
  31. Kshirsagar A.V., Zeitler E.M., Weaver A., Franceschini N., Engel L.S. Environmental exposures and kidney disease. Kidney360. 2022; 3(12): 2174–82. https://doi.org/10.34067/KID.0007962021
  32. Hvidtfeldt U.A., Taj T., Chen J., Rodopoulou S., Strak M., de Hoogh K., et al. Long term exposure to air pollution and kidney parenchyma cancer – Effects of low-level air pollution: a Study in Europe (ELAPSE). Environ. Res. 2022; 215(Pt. 2): 114385. https://doi.org/10.1016/j.envres.2022
  33. Wong E., Peracha J., Pitcher D., Casula A., Steenkamp R., Medcalf J.F., et al. Seasonal mortality trends for hospitalised patients with acute kidney injury across England. BMC Nephrol. 2023; 24(1): 144. https://doi.org/10.1186/s12882-023-03094-5
  34. Grant C.H., Salim E., Lees J.S., Stevens K.I. Deprivation and chronic kidney disease – a review of the evidence. Clin. Kidney J. 2023; 16(7): 1081–91. https://doi.org/10.1093/ckj/sfad028
  35. Bencina G., Chami N., Hughes R., Weston G., Baxter C., Salomonsson S. Assessing the impact of kidney cancer-related premature mortality and productivity loss in Greece and Portugal. Expert Rev. Pharmacoecon. Outcomes Res. 2023; 23(4): 391–8. https://doi.org/10.1080/14737167.2023.2180356
  36. Shcherbakova N.F., Minakova D.V. Economic burden analysis of hemodialysis in the region. Sovremennaya ekonomika: problemy i resheniya. 2019; (1): 93–105. https://doi.org/10.17308/meps.2019.1/2028 https://elibrary.ru/vxkjem (in Russian)
  37. Roberts G., Holmes J., Williams G., Chess J., Hartfiel N., Charles J.M., et al. Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom. Perit. Dial. Int. 2022; 42(6): 578–84. https://doi.org/10.1177/08968608211061126
  38. Kalacheva Zh.M. Disability of the adult population due to diseases of the urinary system and improvement of rehabilitation: Diss. Moscow; 2022.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bibitova S.S., Galiakparova Z.Z., Zhaksylyk M.A., Lopuha I.V., Oralova R.N., Sandybayeva A.K., Khashimov Z.U., Dyussembaeva N.K., Rybalkina D.K., Drobchenko Y.A., Dyagilev M.A., Kosach V.S., 2024



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.